ITM to Host Symposium on Actinium-225 Targeted Radionuclide Therapy and to Present Phase III COMPOSE Trial Design at the Theranostics World Congress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of.
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Fusion Pharmaceuticals Inc. is a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines. The compnay’s lead program includes FPI-1434, […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) CEO John Valliant sold 11,994 shares of Fusion Pharmaceuticals stock in a transaction that occurred on Wednesday, April 13th. The stock was sold at an average price of $6.41, for a total transaction of $76,881.54. Following the transaction, the chief executive officer now directly owns 328,130 shares in […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) CEO John Valliant sold 2,600 shares of the company’s stock in a transaction on Monday, April 11th. The shares were sold at an average price of $7.37, for a total value of $19,162.00. Following the completion of the sale, the chief executive officer now owns 358,379 shares of […]